Derin, D. Et Al. 2008. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer. CANCER INVESTIGATION , vol.26, no.7 , 671-679.

Derin, D., Eralp, Y., Ozluk, Y., Yavuz, E., Guney, N., Saip, P., ... Igci, A.(2008). Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer. CANCER INVESTIGATION , vol.26, no.7, 671-679.

Derin, Duygu Et Al. "Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer," CANCER INVESTIGATION , vol.26, no.7, 671-679, 2008

Derin, Duygu Et Al. "Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer." CANCER INVESTIGATION , vol.26, no.7, pp.671-679, 2008

Derin, D. Et Al. (2008) . "Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer." CANCER INVESTIGATION , vol.26, no.7, pp.671-679.

@article{article, author={Duygu Derin Et Al. }, title={Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer}, journal={CANCER INVESTIGATION}, year=2008, pages={671-679} }